NASDAQ: DFTX · Biotechnology
Over the past week, Definium Therapeutics (DFTX) saw 10 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 39% bullish but is deeply split: Reddit runs 50% bullish while X sits at just 17%. Wall Street is more constructive, with 18 of 18 analysts rating DFTX a buy.
There is little buzz around DFTX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 17% to Reddit at 50%. No other tracker puts the two side by side.
Across 18 analysts the consensus is a Strong Buy: 18 buy calls against 0 sell, with an average 12-month price target of $71.65.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 61 points above the crowd average of 39%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 50% bullish while X sits at 17%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Definium Therapeutics (DFTX) buzz held subdued around 24.7 while the price drifted down 11.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.3M shares. Updated Sep 26, 2026. Over the last 7 trading days, DFTX lost 6.5%. Buzz activity in the recent week averaged 27.6 and was relatively stable, swinging between 24.0 and 35.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 13 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for DFTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live DFTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (18 / 0 / 0) |
| Crowd bullish (7d) | 39% |
| Avg price target | $71.65 |
| Most bullish source | Reddit, 50% |
| Most bearish source | X, 17% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 10 |
| Market cap | $4.94B |
| EPS · Beta | -$3.35 · 2.2 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Definium Therapeutics (DFTX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 39% bullish across 3 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Definium Therapeutics (DFTX) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Definium Therapeutics (DFTX), averaging 39% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 50% bullish and X at 17%, a 33-point spread. On the professional side, 18 of 18 analysts rate DFTX a buy.
Of the 18 analysts covering Definium Therapeutics (DFTX), 18 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $71.65. That puts the street ahead of the crowd, which averages 39% bullish.
Definium Therapeutics (DFTX)'s cross-source average is bearish at 39% bullish. Source readings are split: 1 source leans bearish and 2 sources sit at 50% bullish. Reddit reads 50% bullish, News reads 50% bullish and x coverage is the most negative at 17% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Definium Therapeutics (DFTX) at 39% bullish. Source readings are split: 1 source leans bearish and 2 sources sit at 50% bullish. The most bearish reading is x at 17% bullish. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 6 mentions (60% of total volume). Reddit contributes 2 mentions and News contributes 2 mentions. The cross-source average is bearish at 39% bullish. Source readings are split: 1 source leans bearish and 2 sources sit at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. DFTX's sell signal at 93/100 conviction reflects a bearish cross-source average at 39% bullish. Source readings are split: 1 source leans bearish and 2 sources sit at 50% bullish. It is a research shortcut, not financial advice.
The DFTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key